GI Innovation, Inc. (KOSDAQ: A358570)
Health Care · Biotechnology · KR
₩8,820.00
-0.56% today · -55.4% 1Y
GI Innovation, Inc. (KOSDAQ: A358570) operates in the Biotechnology industry within the Health Care sector. The company is valued at $422.52M.
Over the last twelve months the share price has lost 55.4%, trading between 6.47K and 20.95K.
Tweenvest scores GI Innovation, Inc. across four factors: quality 38/100, value 59/100, growth 58/100. Its strongest factor is value.
A358570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $422.52M
- Revenue (TTM)
- $3.55M
- P/E
- —
- EPS
- -614.06
- Dividend yield
- —
- Beta (5Y)
- 0.94
- 52-week high
- ₩20,950.00
- 52-week low
- ₩6,470.00
- Avg volume (3M)
- —
- Shares outstanding
- 64.52M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.SZSE: 300313 | $431.10M | CN¥12.06 | -2.51% |
| Edding Genor Group Holdings LimitedSEHK: 6998 | $430.01M | HK$1.70 | +1.80% |
| Prothena Corporation plcNasdaqGS: PRTA | $429.18M | $8.48 | +1.44% |
| Egetis Therapeutics AB (publ)OM: EGTX | $425.31M | Skr9.54 | +3.92% |
| Editas Medicine, Inc.NasdaqGS: EDIT | $422.35M | $2.75 | +0.73% |
| Yantai Zhenghai Biotechnology Co., Ltd.SZSE: 300653 | $422.13M | CN¥15.94 | +1.27% |
| Rezolute, Inc.NasdaqCM: RZLT | $420.64M | $4.38 | +9.23% |
| AP Biosciences, Inc.TPEX: 6945 | $416.39M | NT$136.00 | -1.45% |
Figures last refreshed Oct 4, 2026.